šŸ‡ŗšŸ‡ø FDA

Intelligence Ā· Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 30 of 151

  1. CEFAZOLIN, CLOXACILLIN, CLAVULANIC ACID, AMOXICILLIN, AMOXICILLIN

    Pari Pharma GmbH

    acute osteomyelitis of the child

    phase 2 small molecule active

    1 trial

  2. CEFEPIME , AMIKACIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR

    Pari Pharma GmbH

    gram-negative bacillus pneumonia acquired during mechanical ventilation in patients receiving Extracorporeal Membrane veno-arterial oxygenation

    phase 2 small molecule active

    1 trial

  3. CEMIPLIMAB

    Fondazione Telethon ETS

    surgically resectable, high risk stage III/IV (M0) Cutaneaous Squamous Cell Carcinoma, Cutaneaous Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  4. CEP-18770

    Teva Generics B.V

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  5. CEP-18770

    Teva Pharma GmbH

    Multiple Myeloma

    phase 2 small molecule terminated

    2 trials

  6. CEP-37247

    Teva Pharma GmbH

    Sciatica

    phase 2 small molecule completed

    1 trial

  7. CEP-701

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  8. CEP-701

    Teva Pharma GmbH

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  9. CEP-701 20mg

    Teva Pharma GmbH

    Psoriasis

    phase 2 small molecule completed

    1 trial

  10. CEP-701 60mg

    Teva Pharma GmbH

    Leukemia, Myeloid

    phase 2 small molecule completed

    1 trial

  11. CEP-9722

    Teva Pharma GmbH

    Solid Tumors

    phase 2 small molecule terminated

    1 trial

  12. CERC-002

    Avalo Therapeutics

    COVID-19 Pneumonia

    phase 2 small molecule completed

    1 trial

  13. CERC-301

    Avalo Therapeutics

    Major Depressive Disorder

    phase 2 small molecule completed

    2 trials

  14. CERC-501

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 2 small molecule completed

    1 trial

  15. CERE-110: Adeno-Associated Virus injection Surgery

    SANGAMO THERAPEUTICS, INC

    Alzheimer's Disease

    phase 2 small molecule completed

    1 trial

  16. CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])

    SANGAMO THERAPEUTICS, INC

    Idiopathic Parkinson's Disease

    phase 2 small molecule completed

    1 trial

  17. CERE-120: Adeno-Associated Virus Delivery of Neurturin

    SANGAMO THERAPEUTICS, INC

    Idiopathic Parkinson's Disease

    phase 2 mab completed

    1 trial

  18. CET/PT

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    phase 2 other completed

    1 trial

  19. CETUXIMAB , MK-1084, MK-1084, MK-1084, KEYTRUDA 25 mg/mL concentrate for solution for infusion., CARBOPLATIN , PEMETREXED , MK-1084

    Merck Sharp and Dohme

    Participants with KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC

    phase 2 small molecule active

    1 trial

  20. CETUXIMAB , MK-1084, MK-1084, MK-1084, MK-1084

    Merck Sharp and Dohme

    Neoplasm malignant with KRAS G12C mutation

    phase 2 small molecule active

    1 trial

  21. CETUXIMAB, FOLINIC ACID, FLUOROURACIL, IRINOTECAN

    Fondazione Telethon ETS

    ADCC, Colorectal Cancer

    phase 2 small molecule active

    1 trial

  22. CF 102

    Can-Fite BioPharma

    Chronic Hepatitis C

    phase 2 small molecule completed

    1 trial

  23. CF101

    Can-Fite BioPharma

    Uveitis, Posterior

    phase 2 small molecule terminated

    1 trial

  24. CF101

    Can-Fite BioPharma

    Rheumatoid Arthritis

    phase 2 small molecule completed

    3 trials

  25. CF101

    Can-Fite BioPharma

    Ocular Hypertension

    phase 2 small molecule completed

    1 trial

  26. CF101

    Can-Fite BioPharma

    Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  27. CF101 1mg

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 2 small molecule completed

    1 trial

  28. CF102

    Can-Fite BioPharma

    Hepatocellular Carcinoma

    phase 2 small molecule completed

    2 trials

  29. CF102

    Can-Fite BioPharma

    Non-alcoholic Steatohepatitis (NASH)

    phase 2 small molecule completed

    1 trial

  30. CG0070

    CG Oncology

    Non Muscle Invasive Bladder Cancer

    phase 2 mab completed

    1 trial

  31. CG0070

    CG Oncology

    Bladder Cancer

    phase 2 mab completed

    1 trial

  32. CGT4859

    Cogent Biosciences

    Intrahepatic Cholangiocarcinoma (Icc)

    phase 2 small molecule active

    1 trial

  33. CGT9486

    Cogent Biosciences

    Gastrointestinal Stromal Tumors

    phase 2 small molecule completed

    1 trial

  34. CGT9486, CGT9486

    Cogent Biosciences

    Advanced Systemic Mastocytosis

    phase 2 small molecule active

    1 trial

  35. CHF5993 pMDI (100) -152a, CHF5993 pMDI HFA-152a, Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution

    Chiesi Farmaceutici S.p.A

    Mild to moderate asthma

    phase 2 small molecule active

    1 trial

  36. CHF6001 DPI

    Chiesi Farmaceutici S.p.A

    Asthma

    phase 2 small molecule active

    1 trial

  37. CHO-H01

    Cho Pharma

    Non-Hodgkin Lymphoma

    phase 2 small molecule active

    1 trial

  38. CHOP+selinexor+5-Azacitidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 2 small molecule active

    1 trial

  39. CHRONVAC-CĀ®

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis C Virus Infection

    phase 2 small molecule active

    1 trial

  40. CI-581aa

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 2 small molecule completed

    1 trial

  41. CIALIS 5 mg film-coated tablets

    The George Institute

    sexual/ erectile function in women and men after treatment for rectal cancer

    phase 2 small molecule active

    1 trial

  42. CID-103

    CASI Pharmaceuticals

    Chronic Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  43. CIK

    The First People's Hospital of Lianyungang

    Lung Adenocarcinoma

    phase 2 mab terminated

    1 trial

  44. CINRYZE

    Takeda

    Hereditary Angioedema

    phase 2 mab completed

    1 trial

  45. CINRYZE

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 mab completed

    1 trial

  46. CINRYZE with rHuPH20

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 mab completed

    1 trial

  47. CINRYZE with rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Hereditary Angioedema

    phase 2 mab completed

    1 trial

  48. CISPLATIN, CARBOPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion, CISPLATIN, FLUOROURACIL

    Takeda

    Solid Neoplasm

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources Ā· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates ā€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.